Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinovac Biotech : Brazil says China's Sinopharm seeks COVID-19 vaccine emergency-use authorization

07/26/2021 | 11:33am EDT

SAO PAULO, July 26 (Reuters) - China National Pharmaceutical Group Co Ltd (Sinopharm) has applied for emergency use authorization for its COVID-19 vaccine in Brazil, the Brazilian health agency Anvisa said in a statement on Monday.

Brazil already uses another Chinese COVID-19 vaccine, Sinovac Biotech's Coronavac, which is the vaccine most administered in the South American nation.

Sinopharm's vaccine is made from an inactivated virus, Anvisa said, and is recommended for people over age 18. The agency added that it is applied in two doses, with an interval of three to four weeks between them, citing information provided by the manufacturer.

The agency said that it will review over the next day whether the documentation submitted by Sinopharm is complete and that it may request additional information to process the emergency-use application. (Reporting by Anthony Boadle Writing by Ana Mano Editing by Jonathan Oatis and Will Dunham)


ę Reuters 2021
All news about SINOVAC BIOTECH LTD.
09/24CANSINO BIOLOGICS : CanSinoBIO's COVID vaccine, tested at lower dosage, safe for children ..
RE
09/22SINOVAC BIOTECH : Thailand delays plan to re-open cities to tourists until November
RE
09/15INDONESIA IN TALKS WITH WHO TO BECOM : minister
RE
09/09SINOVAC BIOTECH : Says its New Research Shows Third Dose if its COVID-19 Vaccine More Effe..
MT
09/09SINOVAC BIOTECH : New Research on SINOVAC's COVID-19 Vaccine Shows Third Dose More Effecti..
BU
09/08SINOVAC BIOTECH : Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Child..
BU
09/07SINOVAC BIOTECH : Mixing CanSinoBIO, Sinovac COVID shots induces stronger response than Si..
RE
09/01SINOVAC BIOTECH : North Korea turns down Sinovac COVID-19 vaccine doses - WSJ
RE
08/24SINOVAC BIOTECH : COVID-19 booster shots should follow after China inoculates more -state ..
RE
08/23São Paulo City Will Require Proof of Vaccination to Enter Shops, Bars
DJ
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 33,5%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | SVA | AGP8696W1045 | MarketScreener
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED10.18%104 042
WUXI BIOLOGICS (CAYMAN) INC.14.59%65 634
SAMSUNG BIOLOGICS CO.,LTD.11.62%51 879
BIOGEN INC.19.74%43 697
ALEXION PHARMACEUTICALS, INC.0.00%40 336